Oral Microbiome Imbalance in Multiple Sclerosis
Recent research indicates that individuals with multiple sclerosis (MS) exhibit a notably unbalanced oral microbiome. This imbalance is characterized by a decrease in beneficial bacteria and an increase in microbes linked to inflammation. Through advanced genetic and metabolic analysis, scientists found that saliva from MS patients contained lower levels of hypotaurine, a substance important for nerve health and antioxidant defense.
These alterations in the microbial and metabolic landscape suggest that the bacteria in our mouths may play a role in immune dysfunction related to MS. The results could lead to the development of straightforward saliva-based diagnostic methods and innovative treatments aimed at restoring healthy bacterial populations to promote neurological well-being.
Key Findings
- Imbalanced Oral Microbiome: MS patients exhibited reduced beneficial bacteria and an increase in inflammatory microbes in their saliva.
- Distinct Metabolic Profile: Levels of hypotaurine, a crucial protective metabolite, were lower, indicating a link to nerve health.
- Future Clinical Applications: Saliva testing could potentially assist in diagnosing or tracking MS, while restoring healthy oral bacteria might offer a new intervention approach.
Many are already aware of the gut microbiome—the vast collection of bacteria, fungi, and viruses in our digestive system—and how maintaining it can improve overall health. Yet, it turns out other parts of our body, including the mouth, have unique microbiomes that haven’t been as thoroughly studied.
Researchers at the University of Iowa Health Care conducted a comprehensive analysis of the oral microbiome in individuals with MS, a chronic autoimmune condition that affects nerves in the brain and spinal cord. They noted that MS patients have a noticeably different oral microbiome compared to healthy individuals.
“The gut microbiome has often been associated with MS, but we can’t overlook the oral microbiome, which is the second most diverse microbiome in our body,” explains Ashutosh Mangalam, a professor at the university and the senior author of the study published in the journal npj Biofilms and Microbiomes. “Our findings show that individuals with MS have significant differences in the bacteria and metabolites present in their saliva, indicating a disruption in the oral ecosystem.”
While there are treatments available that can slow the progression of MS—symptoms of which include muscle weakness, vision problems, and cognitive issues—there remains no definitive cure. Insights from this study may help medical professionals create simpler saliva tests for detecting or monitoring MS and could lead to therapies focused on restoring healthy bacteria.
Details of the Research
Researchers employed advanced techniques like shotgun metagenomics and untargeted metabolomics to explore how the mouth’s bacterial community and the small molecules it produces might affect MS. They examined saliva from 50 patients with relapsing–remitting MS (the most common form) and compared it to samples from 50 healthy individuals. The study revealed a disrupted oral microbiome in MS patients.
The identified imbalance was marked by a loss of beneficial bacteria that form the foundation of a healthy oral environment, like Streptococcus and Actinomyces, along with an increase in potentially harmful bacteria, such as Fusobacterium nucleatum and Porphyromonas gingivalis. The saliva’s metabolic profile also indicated lower levels of hypotaurine, linking the metabolic changes to the altered bacterial makeup in MS patients.
These findings suggest the possibility that changes in oral bacteria and metabolites could further contribute to inflammation and disease processes in MS. Notably, the researchers developed a unique machine-learning technique called topic modeling, which helped identify distinct bacterial communities and reveal that several were significantly diminished in MS patients. This loss hints at a breakdown in the cooperative interactions necessary for oral health.
“This multi-omics approach has illuminated how the composition of bacteria, their function, and the profiles of metabolites are interconnected,” Mangalam notes. “It sheds light on specific bacterial and metabolic patterns that may influence inflammation and immune regulation in MS.”
Implications for Diagnosis and Treatment
The insights gained from this research could lead to better strategies for diagnosing, monitoring, and treating MS. Saliva collection is straightforward and non-invasive, making the oral microbiome an appealing option for developing biomarkers to track disease activity.
For instance, profiling oral bacteria could help establish diagnostic criteria for MS, and measuring hypotaurine levels might serve as a simple, non-invasive tool for aiding in diagnosis or monitoring progression. Moreover, given that the oral microbiome is more easily accessible than the gut microbiome, these findings could inspire new treatments aimed at healing or replacing unhealthy bacteria, ultimately improving patient outcomes.
The multidisciplinary team behind this research included experts from various fields within the University of Iowa, offering a comprehensive approach to the study of MS.
